The donor pool for high-risk blood cancer patients could be increased through a new stem cell transplant - D.shahrin ahmed
The Leukemia & Lymphoma Society Cure Leukaemia Cancer Research UK Canadian Cancer Society
BonumCE Malignant Hematology CME American Cancer Society Jo Taylor
oncodaily.com/73176.html

#ASCO #Cancer #OncoDaily #Oncology

New treatment for a form of acute myeloid leukaemia approved for use on NHS - UK - D.shahrin ahmed
Leukaemia Care Leukaemia Cancer Blood Cancer Journal BonumCE Malignant Hematology CME Cancer Research UK Canadian Cancer Society OncoDaily ASCO American Cancer Society
oncodaily.com/71525.html

#Cancer #OncoDaily #Oncology

🎥 #MedTwitter #MMsm webinar 👉Selecting BCMA- and GPRC5D-directed Therapies w/ ⭐️s Dr. Marivi Mateos & Dr. Joe Mikhael | + 🆓 #CME x.com/i/broadcasts/1…

GlobalEducationGroup Bonum CE BonumCE Malignant Hematology CME Raj Chakraborty Hareth Nahi Ajay Nooka, MD, MPH Tom Martin Ajai Chari nizar jacques bahlis Rakesh Popat Dr. Amrita Krishnan Aurore Perrot marivi mateos Joseph Mikhael Paula Rodriguez-Otero Prof. Dr. Hermann Einsele Jo Caers Gordon Cook Annemiek Broijl Yvonne Efebera Sagar Lonial MD Krina Patel Surbhi Sidana, MD Adam D Cohen, MD Param Hari Abhinav Deol Betsy O'Donnell Alicia Allred Beth Faiman PhD Shaji Kumar Enrique M Ocio Natalie Callander Muhamed Baljević, MD, FACP Erica Campagnaro Caitlin Costello, MD Luciano J Costa Yi Lin Martin Kaiser Anna Sureda Samer Al Hadidi, MD,MS,FACP Joshua Richter, MD, FACP David S Siegel MD, PhD Emil Hermansen Hearn Jay Cho MD, PhD Mount Sinai Hematology/Oncology Fellowship The Tisch Cancer Institute 💯 Found this #MedTweetorial helpful 🤝?
Stay tuned...
➕more to come tomorrow w/ Joseph Mikhael & Chng Wee Joo on Acute Toxicities

🗓️In November...
✅@MVMateos & Dr. Mikhael 🎥on BCMA- & GPRC5D FDA & EMA approved tx in #MultipleMyeloma

✅Mohamad Mohty & Me 🎥on the future of tx in MM

GlobalEducationGroup Bonum CE BonumCE Malignant Hematology CME Raj Chakraborty 5/ #mmsm
🦠Infections occur frequently in pts receiving BCMA-directed bispecific antibodies & #CART
🦠Frequency of infections: viral > bacterial > fungal
🦠Bacterial infections are more frequent in 1st 30 days; after that viral infections predominate
👇Incidence of infection👇

GlobalEducationGroup Bonum CE BonumCE Malignant Hematology CME 4/ #mmsm #MedTwitter #OncTwitter Raj Chakraborty

✏️Leading cause of death in #MultipleMyeloma is the disease itself
✏️ Based on data prior to approval of BCMA-targeted therapies, infection is the 5️⃣th leading cause of death in patients w/ #Myeloma 👇

5/ #MMsm
🔴Post-Poll Q4️⃣

📊63-YOF dx w/ IgG MM w/ del 17p
She rec'd 5 prior tx inc. 2 PI, 2 IMiDs, & 2 anti-CD38 mAb
She's the caregiver for spouse w/ adv #ALZ
Lives 200 miles from cellular tx center
She wishes to receive treatment close to home
Which Rx is best?

#MMsM Expert Consult w⭐️@MVMateos & Joseph Mikhael

Selecting BCMA & GPRC5D🎯Tx for RRMM

🚦3 quick steps & voilà ~ 🆓 #CME
🔴Watch 🎥👇
🟡Answer post-poll
🟢🏆Claim CME from @BonumCE👉bit.ly/RRMM_EC1
Supported by an edu grant from @Pfizer & JanssenUS

GlobalEducationGroup Bonum CE BonumCE Malignant Hematology CME 3/ #MMsm

🗳️Which of the following is the leading cause of death in patients with #MultipleMyeloma ?